Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective

Ming C Hu, Mingjun Shi, Jianning Zhang, Henry Quĩones, Makoto Kuro-o, Orson W Moe

Research output: Contribution to journalArticle

187 Citations (Scopus)

Abstract

Klotho is an antiaging substance with pleiotropic actions including regulation of mineral metabolism. It is highly expressed in the kidney and is present in the circulation and urine but its role in acute kidney injury (AKI) is unknown. We found that ischemia-reperfusion injury (IRI) in rodents reduced Klotho in the kidneys, urine, and blood, all of which were restored upon recovery. Reduction in kidney and plasma Klotho levels were earlier than that of neutrophil gelatinase-associated lipocalin (NGAL), a known biomarker of kidney injury. Patients with AKI were found to have drastic reductions in urinary Klotho. To examine whether Klotho has a pathogenic role, we induced IRI in mice with different endogenous Klotho levels ranging from heterozygous Klotho haploinsufficient, to wild-type (WT), to transgenic mice overexpressing Klotho. Klotho levels in AKI were lower in haploinsufficient and higher in transgenic compared with WT mice. The haploinsufficient mice had more extensive functional and histological alterations compared with WT mice, whereas these changes were milder in overexpressing transgenic mice, implying that Klotho is renoprotective. Rats with AKI given recombinant Klotho had higher Klotho protein, less kidney damage, and lower NGAL than rats with AKI given vehicle. Hence, AKI is a state of acute reversible Klotho deficiency, low Klotho exacerbates kidney injury and its restoration attenuates renal damage and promotes recovery from AKI. Thus, endogenous Klotho not only serves as an early biomarker for AKI but also functions as a renoprotective factor with therapeutic potential.

Original languageEnglish (US)
Pages (from-to)1240-1251
Number of pages12
JournalKidney International
Volume78
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Reperfusion Injury
Acute Kidney Injury
Biomarkers
Kidney
Transgenic Mice
Urine
Wounds and Injuries
Minerals
Rodentia

Keywords

  • acute kidney injury
  • biomarker
  • ischemia-reperfusion injury
  • Klotho
  • neutrophil gelatinase-associated lipocalin
  • therapy

ASJC Scopus subject areas

  • Nephrology

Cite this

Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. / Hu, Ming C; Shi, Mingjun; Zhang, Jianning; Quĩones, Henry; Kuro-o, Makoto; Moe, Orson W.

In: Kidney International, Vol. 78, No. 12, 12.2010, p. 1240-1251.

Research output: Contribution to journalArticle

Hu, Ming C ; Shi, Mingjun ; Zhang, Jianning ; Quĩones, Henry ; Kuro-o, Makoto ; Moe, Orson W. / Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. In: Kidney International. 2010 ; Vol. 78, No. 12. pp. 1240-1251.
@article{d29fcc281ced4659b01b80b0661a26f1,
title = "Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective",
abstract = "Klotho is an antiaging substance with pleiotropic actions including regulation of mineral metabolism. It is highly expressed in the kidney and is present in the circulation and urine but its role in acute kidney injury (AKI) is unknown. We found that ischemia-reperfusion injury (IRI) in rodents reduced Klotho in the kidneys, urine, and blood, all of which were restored upon recovery. Reduction in kidney and plasma Klotho levels were earlier than that of neutrophil gelatinase-associated lipocalin (NGAL), a known biomarker of kidney injury. Patients with AKI were found to have drastic reductions in urinary Klotho. To examine whether Klotho has a pathogenic role, we induced IRI in mice with different endogenous Klotho levels ranging from heterozygous Klotho haploinsufficient, to wild-type (WT), to transgenic mice overexpressing Klotho. Klotho levels in AKI were lower in haploinsufficient and higher in transgenic compared with WT mice. The haploinsufficient mice had more extensive functional and histological alterations compared with WT mice, whereas these changes were milder in overexpressing transgenic mice, implying that Klotho is renoprotective. Rats with AKI given recombinant Klotho had higher Klotho protein, less kidney damage, and lower NGAL than rats with AKI given vehicle. Hence, AKI is a state of acute reversible Klotho deficiency, low Klotho exacerbates kidney injury and its restoration attenuates renal damage and promotes recovery from AKI. Thus, endogenous Klotho not only serves as an early biomarker for AKI but also functions as a renoprotective factor with therapeutic potential.",
keywords = "acute kidney injury, biomarker, ischemia-reperfusion injury, Klotho, neutrophil gelatinase-associated lipocalin, therapy",
author = "Hu, {Ming C} and Mingjun Shi and Jianning Zhang and Henry Quĩones and Makoto Kuro-o and Moe, {Orson W}",
year = "2010",
month = "12",
doi = "10.1038/ki.2010.328",
language = "English (US)",
volume = "78",
pages = "1240--1251",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective

AU - Hu, Ming C

AU - Shi, Mingjun

AU - Zhang, Jianning

AU - Quĩones, Henry

AU - Kuro-o, Makoto

AU - Moe, Orson W

PY - 2010/12

Y1 - 2010/12

N2 - Klotho is an antiaging substance with pleiotropic actions including regulation of mineral metabolism. It is highly expressed in the kidney and is present in the circulation and urine but its role in acute kidney injury (AKI) is unknown. We found that ischemia-reperfusion injury (IRI) in rodents reduced Klotho in the kidneys, urine, and blood, all of which were restored upon recovery. Reduction in kidney and plasma Klotho levels were earlier than that of neutrophil gelatinase-associated lipocalin (NGAL), a known biomarker of kidney injury. Patients with AKI were found to have drastic reductions in urinary Klotho. To examine whether Klotho has a pathogenic role, we induced IRI in mice with different endogenous Klotho levels ranging from heterozygous Klotho haploinsufficient, to wild-type (WT), to transgenic mice overexpressing Klotho. Klotho levels in AKI were lower in haploinsufficient and higher in transgenic compared with WT mice. The haploinsufficient mice had more extensive functional and histological alterations compared with WT mice, whereas these changes were milder in overexpressing transgenic mice, implying that Klotho is renoprotective. Rats with AKI given recombinant Klotho had higher Klotho protein, less kidney damage, and lower NGAL than rats with AKI given vehicle. Hence, AKI is a state of acute reversible Klotho deficiency, low Klotho exacerbates kidney injury and its restoration attenuates renal damage and promotes recovery from AKI. Thus, endogenous Klotho not only serves as an early biomarker for AKI but also functions as a renoprotective factor with therapeutic potential.

AB - Klotho is an antiaging substance with pleiotropic actions including regulation of mineral metabolism. It is highly expressed in the kidney and is present in the circulation and urine but its role in acute kidney injury (AKI) is unknown. We found that ischemia-reperfusion injury (IRI) in rodents reduced Klotho in the kidneys, urine, and blood, all of which were restored upon recovery. Reduction in kidney and plasma Klotho levels were earlier than that of neutrophil gelatinase-associated lipocalin (NGAL), a known biomarker of kidney injury. Patients with AKI were found to have drastic reductions in urinary Klotho. To examine whether Klotho has a pathogenic role, we induced IRI in mice with different endogenous Klotho levels ranging from heterozygous Klotho haploinsufficient, to wild-type (WT), to transgenic mice overexpressing Klotho. Klotho levels in AKI were lower in haploinsufficient and higher in transgenic compared with WT mice. The haploinsufficient mice had more extensive functional and histological alterations compared with WT mice, whereas these changes were milder in overexpressing transgenic mice, implying that Klotho is renoprotective. Rats with AKI given recombinant Klotho had higher Klotho protein, less kidney damage, and lower NGAL than rats with AKI given vehicle. Hence, AKI is a state of acute reversible Klotho deficiency, low Klotho exacerbates kidney injury and its restoration attenuates renal damage and promotes recovery from AKI. Thus, endogenous Klotho not only serves as an early biomarker for AKI but also functions as a renoprotective factor with therapeutic potential.

KW - acute kidney injury

KW - biomarker

KW - ischemia-reperfusion injury

KW - Klotho

KW - neutrophil gelatinase-associated lipocalin

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=78649642147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649642147&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.328

DO - 10.1038/ki.2010.328

M3 - Article

C2 - 20861825

AN - SCOPUS:78649642147

VL - 78

SP - 1240

EP - 1251

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 12

ER -